Superhuman Surgery with Moon Surgical and Maestro - Ep. 272

What It Covers

Moon Surgical CEO Anne Ostroh explains how their Maestro platform augments surgeons with AI-controlled robotic arms, reducing procedure variability and surgeon fatigue while maintaining human control in minimally invasive surgery across 2,000 patients.

Key Questions Answered

• •Surgeon autonomy design: Maestro gives surgeons direct control over camera positioning and tissue exposure through two additional robotic arms, eliminating coordination delays with surgical assistants and enabling personalized surgical preferences unique to each surgeon's technique and patient anatomy.
• •Physical AI implementation: Moon deployed the first FDA-cleared physical AI system in operating rooms that automates camera movements, with subsequent regulatory approval to evolve the AI algorithm continuously without requiring new FDA submissions for each update, accelerating feature deployment timelines.
• •Clinical outcomes data: Early results show reduced variability in procedure times and increased surgical quality across cases. Surgeons report significantly lower physical and mental fatigue, with one surgeon noting improved mood at home after 50 cases using the system versus traditional assisted surgery.
• •Workflow optimization roadmap: The platform's extensive sensing capabilities enable dynamic OR scheduling with real-time procedure end-time predictions, optimized staff deployment based on surgeon autonomy levels, automated inventory management, and AI-generated surgical reports that currently don't exist due to surgeon time constraints.